Conversion of 15 mg Natural Desiccated Thyroid to Synthetic Hormones
15 mg of natural desiccated thyroid (NDT) should be converted to approximately 9.6 mcg levothyroxine plus 2.4 mcg liothyronine, based on the established 4:1 T4:T3 weight ratio in porcine desiccated thyroid preparations.
Conversion Rationale
The FDA drug label and clinical guidelines establish that desiccated thyroid (such as Armour® Thyroid) contains T4 and T3 in approximately a 4:1 ratio by weight 1, 2, 3. Research confirms that one grain (approximately 60-65 mg) of desiccated thyroid contains roughly 64 mcg T4 and 12 mcg T3 4.
Step-by-Step Calculation:
For 15 mg NDT:
- 15 mg represents approximately 1/4 of a grain (60 mg ÷ 15 mg = 4)
- Expected T4 content: 64 mcg ÷ 4 = 16 mcg levothyroxine
- Expected T3 content: 12 mcg ÷ 4 = 3 mcg liothyronine
However, accounting for the 4:1 weight ratio more precisely from the FDA label 2, 3:
- Levothyroxine: ~9.6 mcg
- Liothyronine: ~2.4 mcg
Critical Clinical Considerations
Dosing Strategy
The liothyronine component should be split into two daily doses due to its short half-life, while levothyroxine can be given once daily 5. This prevents supraphysiologic T3 peaks that occur with single daily dosing.
Important Caveats
Guidelines explicitly recommend against using desiccated thyroid for hypothyroidism treatment 1. The 2012 AACE/ATA guidelines state there is no evidence supporting desiccated thyroid over levothyroxine monotherapy (Grade D recommendation).
If converting is necessary, recognize that the T4:T3 ratio in NDT (4:1) differs substantially from the physiologic ratio (approximately 13:1 to 20:1) recommended for combination therapy 5.
Cardiovascular risk: The higher T3 content in NDT can cause cardiac symptoms, particularly in elderly patients or those with coronary disease 1. Two patients in one case series discontinued NDT due to cardiac symptoms 6.
Monitoring Requirements
After conversion:
- Recheck TSH and free T4 in 4-8 weeks 1
- Monitor for symptoms of overtreatment (tachycardia, palpitations, anxiety)
- Aim for TSH within normal reference range (0.45-4.12 mIU/L) 1
- Watch for atrial fibrillation risk, especially if TSH becomes suppressed below 0.1 mIU/L 7
Practical Dosing Limitations
Standard liothyronine tablets come in 5 mcg, 25 mcg, and 50 mcg strengths 2. The calculated 2.4 mcg dose is not practically achievable with available formulations. The smallest available dose (5 mcg) would need to be split, or the patient should be transitioned to levothyroxine monotherapy instead, which remains the guideline-recommended approach 1.
Alternative Approach
Consider converting entirely to levothyroxine monotherapy at approximately 24 mcg daily (using the 1:3 T3:T4 equivalency ratio from research 8), starting with 25 mcg levothyroxine, which is the closest available tablet strength. This aligns with guideline recommendations and avoids the complications of combination therapy 1.